Angiographic Restenosis and Clinical Recurrence After Sirolimus- and Paclitaxel-Eluting Stent Implantation*
Pieter J. Vlaar, MSc*,
Felix Zijlstra, MD, PhD
Department of Cardiology, University Medical Center Groningen, Thorax Center, Groningen, the Netherlands
View larger version (32K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 1 Late Luminal Loss After SES and PES Implantation
Late luminal loss after SES and PES implantation in trials with protocol mandated follow-up angiography. *In-segment instead of in-stent late luminal loss. Abbreviations as in Table 1.
|
|
View larger version (36K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 2 In-Stent Restenosis Rates of SES and PES
In-stent restenosis rates of SES and PES in trials with protocol-mandated follow-up angiography. *In-segment instead of in-stent restenosis. Abbreviations as in Table 1.
|
|
|
